Direkt zum Inhalt
Merck
  • Inhibition of CYFIP2 promotes gastric cancer cell proliferation and chemoresistance to 5-fluorouracil through activation of the Akt signaling pathway.

Inhibition of CYFIP2 promotes gastric cancer cell proliferation and chemoresistance to 5-fluorouracil through activation of the Akt signaling pathway.

Oncology letters (2017-04-30)
Shuhua Jiao, Nuo Li, Shuang Cai, Haimei Guo, Yanhui Wen
ZUSAMMENFASSUNG

Gastric cancer is a common gastrointestinal malignancy that accounts for a notable proportion of cancer-associated mortalities worldwide. Cytoplasmic fragile X mental retardation 1-interacting protein 2 (CYFIP2) is a novel p53-mediated pro-apoptotic protein whose expression is decreased in gastric cancer. However, whether decreased expression of CYFIP2 contributes to gastric carcinogenesis remains unclear. In order to mimic

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Adenosin-5′-diphosphoribose Natriumsalz, ≥93%
Sigma-Aldrich
(Tyr[SO3H]27)Cholecystokinin-Fragment 26-33 Amid, ≥97% (HPLC), powder
Sigma-Aldrich
MISSION® esiRNA, targeting human CYFIP2